Introduction
The epidemiology of swine influenza (SI) has become increasingly complex over the last decade. Three influenza A virus subtypes -H1N1, H3N2 and H1N2 -are currently circulating in swine worldwide, but the origins and the antigenic and genetic characteristics of these swine influenza virus (SIV) subtypes differ in different continents or regions of the world. 1 The first significant outbreaks of SI on the European mainland occurred in the late 1970s after the transmission of an H1N1 virus from wild ducks to pigs. 2 This 'avian-like' H1N1 virus has become established in the European pig population and ultimately became the dominant H1N1 SIV strain. 3 Viruses of human origin, A ⁄ Hong Kong ⁄ 68-like H3N2 formed a stable lineage in European pigs since the early 1970s, but reassortant H3N2 viruses with human haemagglutinin (HA) and neuraminidase (NA) genes and avian-like swine H1N1 internal protein genes have become dominant since the mid 1980s. 4, 5 Finally, 'triple reassortant' H1N2 viruses have been isolated frequently from pigs throughout Europe since the mid 1990s. [6] [7] [8] [9] [10] These viruses contain an HA of human influenza virus origin, a NA of swine H3N2 virus origin and internal protein genes of avian-like swine H1N1 virus origin. 11 The HA of these H1N2 viruses shows low antigenic and genetic homology (70AE4% amino acid identity in the HA1 region) with avian-like H1N1 viruses and there is no cross-reaction between H1N1 and H1N2 viruses in the HI test. 12 Though most SIV infections are clinically mild or subclinical, all three subtypes have been associated frequently with typical outbreaks of 'swine flu' and SIV may be responsible for up to 50% of acute respiratory disease outbreaks in pigs. 1 Viruses of H1N1 and H3N2 SIV subtypes are considered widespread and endemic in pig populations in Austria, Belgium, Denmark, France, Germany, Great Britain, Italy, The Netherlands and Spain. 13 Occasional serological investigations of pigs sampled at slaughter have been performed in most of these countries in the 1980s and early 1990s and revealed seropositivity to H1N1 and H3N2 in >50% of the tested population. However, over the last few years H3N2 activity is believed to be low or absent in France (Brittany) and Great Britain (Brown I., Veterinary Laboratories Agency, Weybridge, UK, unpublished observations; KuntzSimon G., Agence Française de Sécurité Sanitaire des Aliments, Ploufragan, France, personal communication). Either or both subtypes have also been reported in Bulgaria, the former Czechoslovakia, Greece, Hungary, Ireland, Macedonia, Poland and Sweden. 13 As for the H1N2 virus, a limited serosurvey in sows in Belgium in 1999 has shown seropositivity in 69% of the 443 sera examined. 7 However, there is limited H1N2 seroprevalence data for other European countries and there is little information on the evolution of H1N1 or H3N2 seroprevalence rates in Europe.
The 'European Surveillance Network for Influenza in Pigs 1' (ESNIP1) was a concerted action in the 5th Framework Research Programme of the European Commission   (QLK2-CT-2000-01636, 01-01-2001 until 31- ) that involved 14 partners from 10 different European countries. This action was initiated through the need for standardisation of diagnostic techniques for SI and for a more organised surveillance. The present paper reports the results of a first international serosurvey undertaken by ESNIP1 partners from Belgium, the Czech Republic, France, Italy, Ireland and Poland and by voluntary participants from Germany and Spain. The study aimed to determine the seroprevalence of the novel H1N2 virus in different geographic regions of Europe, and to compare the relative prevalences of each SIV between countries and regions where possible.
Materials and methods

Serum samples
European Surveillance Network for Influenza in Pigs 1 partners from Belgium, the Czech Republic, Italy, Ireland and Poland together with diagnostic laboratories from Germany (Impfstoffwerk Dessau-Tornau, Rodleben) and Spain (Laboratorios HIPRA, Amer) participated in the serosurvey. Serum samples were collected from first parity sows (i.e. sows younger than a year old) only (Italy, Poland) or from sows of various ages (other countries) during 2002 and 2003. None of the animals had been vaccinated against SIV and they originated from herds with a minimum of 100 sows. A total of 4190 sera from 651 farms were collected. Details on sample origin and sample size in the different countries are given in Table 1 . In Belgium, Germany, Italy and Spain, sera were collected from regions containing the highest density of pigs. These regions included 10 of the 19 main swine production regions in the 15 countries comprising the EU until 2004. In the Czech Republic, Ireland and Poland, sera from larger areas or from throughout the country were examined. 14 All sera were treated with receptor-destroying enzyme from Vibrio cholerae and adsorbed with chicken red blood cells to remove non-specific inhibitors of agglutination and natural serum agglutinins respectively. Twofold serum dilutions were tested starting at a dilution 1:20. Haemagglutination-inhibition tests were performed with four haemagglutinating units (HAU) of virus and 0AE5% chicken red blood cells. Titres were expressed as the reciprocal of the highest dilution inhibiting four HAU. The H1N1 and H3N2 strains used in HI tests were representative of avian-like swine and human-avian reassortants respectively and they differed between countries. All countries except the Czech Republic and Poland used local H1N1 and H3N2 strains isolated during the last 15 years, which had been shown to be appropriate for the serological detection of SIV isolated in the respective countries during the study period. The H1N1 strains were as follows:
(Germany) and sw ⁄ Spain ⁄ 46356 ⁄ 03 (Spain). Two H1N2 isolates with some antigenic differences in their HA, sw ⁄ Scotland ⁄ 94 and sw ⁄ England ⁄ 96, 11 were used by all participants. Both H1N2 isolates have a human-like HA and they do not cross-react with avian-like H1N1 viruses in cross-HI tests with post-infection swine sera 12 or sera prepared in ferrets or chickens. 7, 8, 11 Pigs with an antibody titre ‡20 to a given subtype were considered seropositive for that subtype. A farm with one or more seropositive pigs for a given subtype was considered positive for that subtype.
Results
Seroprevalence of H1N1, H3N2 and H1N2 SIV in the sow population Table 2 shows the number and percentage of seropositive sows to tested SIV and the geometric mean antibody titre of the positive animals in each of the seven countries. The incidence of antibodies to H1N2 was higher in HI tests with Scotland ⁄ 94 than in tests with Engand ⁄ 96. A total of 1061 sera tested positive to H1N2: of these 45AE6% were positive to both H1N2 strains, 49AE3% were positive to Scotland ⁄ 94 alone and 5AE1% were positive to England ⁄ 96 alone. Only 10 of the total 651 H1N2-positive farms were positive to England ⁄ 96, usually at low antibody titres, and not to Scotland ⁄ 94. This indicates that Scotland ⁄ 94 is most representative for the H1N2 viruses circulating in European pigs and therefore only serological responses to the Scotland strain are further discussed.
In Belgium, Germany, Italy and Spain, a minority of the sows were negative to all SIV tested. Seroprevalence rates for H1N1 and H3N2 were higher than 50% in Belgium (80AE8% and 53AE8% respectively) and in Germany (70AE8% and 58AE6% respectively) but slightly lower in Italy (46AE4% and 41AE7% respectively) and Spain (38AE5% and 38AE0% respectively). The seroprevalence rate for H1N2 was higher than 50% in Belgium and Spain (57AE8 and 52AE8% respectively), 32AE1% in Germany but lower in Italy (13AE8%). Belgium  600  485  80AE8  75AE98  323  53AE8  43AE21  347  57AE8  40AE08  160  26AE7  36AE36  36  6AE0  Germany  811  574  70AE8  107AE58  475  58AE6  178AE65  260  32AE1  59AE49  158  19AE5  49AE16  120  14AE8  Italy  456  212  46AE4  75AE18  190  41AE7  77AE70  63  13AE8  41AE34  32  7AE0  46AE55  170  37AE3  Spain  600  231  38AE5  114AE12  228  38AE0  194AE48  317  52AE8  160AE83  181  30AE2  86AE48  125  20AE8  Czech Rep.  555  65  11AE7  58AE10  4  0AE1  56AE56  17  3AE0  32AE62  7  1AE3  44AE16  483  87AE0  Ireland  527  94  17AE8  64AE59  22  4AE2  62AE17  3  0AE6  63AE49  0  0  0  415  78AE8  Poland  641  51  8AE0  91AE60  0 In the Czech Republic, Ireland and Poland, most sows were negative for antibodies to all SIV tested. In these countries seroprevalence rates for H1N1 (11AE7, 17AE8 and 8AE0% respectively) were clearly lower than in Belgium, Germany, Italy and Spain. Antibodies to H3N2 and H1N2 were found occasionally in the Czech Republic and in Ireland but were not detected in Poland.
Geometric mean antibody titres were largely comparable between the countries participating in ESNIP1. Spain reported higher mean antibody titres to each SIV subtype, and Germany reported relatively high titres to H1N1 and H3N2.
Seroprevalence of H1N1, H3N2 and H1N2 SIV on a farm basis Table 3 shows SIV seroprevalence rates at the farm level in the seven European countries. The proportion (%) of seropositive farms in each country correlated with the proportion (%) of seropositive sows but was higher, because antibodies to a given SIV subtype were usually present in only part of the sow population from the same herd. In Belgium, Italy and Spain, for example, where exactly six animals per farm were sampled, the median number of H1N1 seropositive sows per farm was five, three and four respectively. Similar within herd seroprevalences were found for H3N2 and H1N2.
In Belgium, Germany and Spain SIV seronegative farms were rare (1AE0-4AE0%), while 11AE8% of the Italian farms tested SIV seronegative. Furthermore, seroprevalence rates for all three subtypes were higher than 50% in these countries, with the exception of the H1N2 seroprevalence rate in Italy (35AE5%).
Fewer SIV seropositive farms were detected in Ireland and the Central European countries. In the Czech Republic and Ireland, approximately 40% of the farms were positive for H1N1 and seropositivity rates for the other subtypes were considerably lower. The small number of sows with H3N2 antibodies in the Czech Republic (4) and with H1N2 antibodies in Ireland (3) originated from different farms. In Poland, where only H1N1 antibodies were detected, only 9% of the farms were seropositive.
Incidence of infections with multiple SIV subtypes in sows
The individual serological data of all countries were further analyzed to determine the proportion (%) of sows that had been infected with multiple SIV subtypes (Table 4 ). In the four countries with highest SIV seroprevalences, the proportion (%) of sows with simultaneous presence of antibodies to two or three different subtypes exceeded the proportion (%) of sows with antibodies to only a single subtype. In the remaining countries, most (Czech Republic, Ireland) or all sows (Poland) had antibodies to H1N1 only.
Discussion
This limited but targeted serological survey was undertaken to determine the prevalence of H1N2 SIV in different European countries and to compare it with that of H1N1 and H3N2. The approach used varied somewhat between countries: there were differences in sample numbers, the age of the sows sampled, the time of sample collection, and the H1N1 and H3N2 strains used as antigens in the HI test. In contrast the strength of the study, was that all participants used identical H1N2 strains and a standardized protocol for the HI test. To assure quality control and standardisation of HI test results, ESNIP1 partners participated in HI ring trials, i.e. parallel tests with well defined SIV and sera. Our data clearly show two distinct SIV seroprevalence patterns. In Belgium, Germany, Italy and Spain, H1N2 has become widespread and cocirculates with H1N1 and H3N2, which have been enzootic in these countries 13 This is in line with the isolation of all three subtypes from acute respiratory disease outbreaks in these countries during the study period (ESNIP1, unpublished data). In the Czech Republic, Ireland and Poland, in contrast, both H1N2 and H3N2 are either undetectable or found at very low levels. The dominant subtype in these countries is clearly H1N1 but its prevalence is lower than in the first series of countries.
The interpretation of HI test results for SIV is more complicated now than in the 1980s, when only H1N1 and H3N2 were present in European swine populations. The three subtypes examined in this study have antigenically distinct HA and serological cross-reactions in the HI test are rare but cannot be excluded. In an experimental study, only eight of the 160 sera collected after infection of pigs with one or two SIV subtypes showed cross-reactive antibodies to another subtype in the HI test. 15 As an example, some pigs that had been infected sequentially with H1N2 and H1N1 showed low (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) HI antibody titres to H3N2 without having been exposed to this subtype. In the present study, the few positive sera to H3N2 in the Czech Republic and to H1N2 in Ireland may result from such serological cross-reactions. This is emphasised by the fact that, with one exception, all these sera were also positive to one or both other subtypes in the HI test. A second important variable is the antigenic and genetic diversity among SI H1N2 viruses in Europe. The heterogeneity within H1N2 viruses is reflected by the higher seroprevalence rates with the Scotland ⁄ 94 isolate than with the antigenically distinguishable England ⁄ 96 isolate. More importantly, novel H1N2 reassortants comprising an HA of avian-like swine H1N1 virus origin have been detected in France, Italy and Denmark. 8, 16, 17 This second generation of H1N2 viruses is antigenically unrelated to the older H1N2 viruses like sw ⁄ Scotland ⁄ 94 and sw ⁄ England ⁄ 96, which derived the HA gene from human H1N1 viruses circulating during the early 1980s. The prevalence of this antigenic variant of H1N2 viruses remains unknown and it cannot be deduced from our study, because the HI test cannot distinguish between such second generation H1N2 viruses and avianlike H1N1 viruses. HI tests will also fail to discriminate between infection with the first generation of H1N2 viruses and novel H1N1 reassortants with a human-like HA, which have been reported occasionally. 8, 17 Nevertheless, the high infection rates with SIV possessing human HA in Western Europe indicate that inclusion of a human-like H1N2 virus in current vaccines would be justified. The current commercial SIV vaccines contain only H1N1 and H3N2 components and they confer little if any protection against the human-like H1N2 virus. 18, 19 The relatively low SI activity in Ireland and the two central European countries can in part be explained by the lower pig density and ⁄ or differences in the structure of the pig industry. As is the case with other respiratory viruses, high regional pig density, larger herd size, shorter distances between herds and a larger size of neighbouring herds all increase the risk of infection with SIV. 20 Ireland has fewer pigs than the other Western European countries examined 21 and an isolated geographic position. The human-like H1N2 viruses, which are likely to have their origin in the UK, 8 The number of pigs produced per year and per farm, however, is significantly lower (approx. 16) than in an average farm in Western Europe (approx. 94). 22 Clearly, avian-like H1N1 SIV are circulating in both Poland and the Czech Republic and this is supported by serological and virological investigations. [23] [24] [25] [26] [27] In contrast, H3N2 or H1N2 SIV, have never been isolated in Poland or in the Czech Republic to date and our present data support the belief that they are absent or epidemiologically unimportant. The This suggests that H3N2 and H1N2 may circulate exclusively in the east of Poland and not in the west, where the samples for the present study were collected, but further confirmation is needed.
In the four countries with high SIV seroprevalences 25AE44-38AE17% of the sows had antibodies to two subtypes and 7AE02-30AE17% were positive for all three subtypes. Thus, H1N1, H1N2 and H3N2 viruses with antigenically distinct HA are not only circulating concurrently, but they also frequently cause consecutive or mixed infections. This therefore provides an opportunity for genetic reassortment to occur between these viruses and this has led to the emergence and maintenance of phylogenetically diverse SIV in pigs in Europe. 8, 16, 17 While antigenic drift within a given virus subtype is less important in pigs than in horses or humans, 3 more influenza virus genotypes are apparently circulating in pigs compared with other mammalian species. Humans are also susceptible to H1N1 and H3N2 viruses that are antigenically distinguishable from their counterparts in pigs, and H1N2 reassortants have been isolated from humans since 2001. 28 However, the human H1N2 viruses still have a similar HA to contemporary human H1N1 strains. 28, 29 The epidemiology of SI, unlike that of human influenza viruses, is entirely different in different continents. In the USA H1N1, H3N2 and H1N2 SIV are also enzootic, but their origin and evolution differs from that of the European viruses and several different genotypic variants of reassortant viruses have also been isolated from pigs in North America. 1 The extensive circulation of SIV in swine dense regions and the occurrence of co-infections are facilitated by the continual availability of young non-immune pigs that have lost their maternal immunity. Indeed, the vast majority of pigs are killed at the age of 6 months and the feeder and fattening pig population has a rapid turn over, so that susceptible individuals are continuously available.
The aim of this serosurvey was to gain preliminary insights to the epidemiology of SI in Europe and many questions remain unanswered. The future epidemiology through cocirculation of H1N1, H3N2 and H1N2 viruses remains uncertain, potentially including the emergence of a dominant subtype or genotype. The importance of the new, second generation reassortant viruses requires careful monitoring. Determination of the SIV prevailing in other central European countries is important together with epidemiological impacts resulting from greater integration of production enhanced through cooperation with companies and investors in Western Europe. This could result in a higher prevalence of SIV and establishment of new SIV subtypes in the future in these countries. These and other issues are being addressed through the 2nd European Surveillance Network for Influenza in Pigs (ESNIP2, SSPE-CT-2005-022749, 01 ⁄ 06 until 12 ⁄ 08). This latter co-ordination action also includes partners from the US and Asia, which will facilitate greater global interaction and worldwide understanding of the epidemiology of SIV. We also intend to interact with human and avian influenza surveillance networks to gain insights into the antigenic and genetic relationships of influenza viruses of different species.
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